Recent Updates
Recently added Catalysts
ALNY Positive Sentiment

Alnylam to Webcast Presentations at Upcoming December Investor Conferences

Key Takeaway: Alnylam Pharmaceuticals will present at two investor conferences on December 3, 2026. The Piper Sandler 38th Annual Healthcare Conference will take place in New York City, followed by Citi's Global Healthcare Conference in Miami. Live webcasts will be available, with replays posted on the company's website.

Market Sentiment Analysis

POSITIVE FACTORS

  • Alnylam is a leader in RNAi therapeutics.
  • The company has seven approved medicines.
  • Alnylam is recognized as an exceptional workplace.
  • The pipeline is rapidly expanding.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+5%
120-day peak, hindsight
Typical move
2.6%
average across 15 past catalysts
Lead asset
ALN-4324
Phase 2 · Type 2 Diabetes Mellitus (T2DM)

Full Press Release Details

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present company overviews at the following upcoming investor conferences:
• Piper Sandler 38th Annual Healthcare Conference on Thursday, December 3, 2026, at 8:30 a.m. ET in New York City
• Citi’s 2026 Global Healthcare Conference on Thursday, December 3, 2026, at 10:20 a.m. ET in Miami
A live audio webcast of each presentation will be available on the Investors section of the Company’s website at www.alnylam.com/events. A replay will be posted on the website within 48 hours after each event.
About Alnylam Pharmaceuticals
Alnylam (Nasdaq: ALNY) is a leading global biopharmaceutical company and the pioneer of the RNA interference (RNAi) revolution. The Company is focused on developing transformative therapies with the potential to prevent, halt, or reverse disease. For more than two decades, Alnylam has advanced the Nobel Prize-winning science of RNAi, delivering critical breakthroughs and seven approved medicines. Alnylam has medicines available in more than 70 countries and a robust and rapidly expanding pipeline, in addition to consistently being recognized as an exceptional workplace and socially responsible organization. The Company is executing its Alnylam 2030 strategy to accelerate innovation and scale impact to transform human health. For more information, visit www.alnylam.com or follow Alnylam on X, LinkedIn, Facebook, Instagram, or YouTube.

Frequently Asked Questions

When does Alnylam present at conferences?

Management presents on December 3, 2026, at Piper Sandler and Citi events.

Where are the investor conferences held?

The Piper Sandler conference is in New York City, and Citi’s is in Miami.

How can investors watch the presentations?

Live audio webcasts are available on the Investors section of alnylam.com.

When are replays posted online?

Replays are posted on the website within 48 hours after each event.

Last updated: Nov 20, 2026